{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:30:13Z","timestamp":1761823813277,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.canrad.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T11:32:54Z","timestamp":1466595174000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003"],"prefix":"10.1016","volume":"20","author":[{"given":"J.-M.","family":"Cosset","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Flam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Belin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Thiounn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pierrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pontvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wakil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Savignoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Chauveinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2016.02.009_bib0190","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/01.ju.0000152558.63996.29","article-title":"Intermediate term biochemical-free progression and local control following 125 iodine brachytherapy for prostate cancer","volume":"173","author":"Stone","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0195","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/01.ju.0000154633.73092.8e","article-title":"12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer","volume":"173","author":"Potters","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0200","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ijrobp.2005.09.005","article-title":"Disease-specific survival following the brachytherapy management of prostate cancer","volume":"64","author":"Stock","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00345-006-0083-1","article-title":"Long-term results of interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer","volume":"24","author":"Machtens","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2006.08.056","article-title":"Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation","volume":"67","author":"Zelefsky","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.brachy.2014.11.015","article-title":"Permanent seed brachytherapy for clinically localized prostate cancer: long-term outcomes in a 700 patient cohort","volume":"14","author":"Martinez","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2016.02.009_bib0220","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00345-015-1480-0","article-title":"Ten-year outcomes of I125 low-dose-rate brachytherapy for clinically localized prostate cancer: a single-institution experience in Japan","volume":"33","author":"Hayashi","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0225","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ijrobp.2007.11.056","article-title":"Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie\/Cochin Hospital\/Necker Hospital group on 809 patients","volume":"71","author":"Cosset","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","article-title":"Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group","volume":"109","author":"Grimm","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2016.02.009_bib0235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.canrad.2014.05.014","article-title":"Results of a cohort of 200 hormone-na\u00efve consecutive patients with prostate cancer treated with iodine 125 permanent interstitial brachytherapy by the same multidisciplinary team","volume":"18","author":"Bolla","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.02.009_bib0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11764-014-0419-6","article-title":"Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study","volume":"9","author":"Drummond","year":"2015","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.canrad.2016.02.009_bib0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11764-013-0312-8","article-title":"Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study","volume":"8","author":"Darwish-Yassine","year":"2014","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.canrad.2016.02.009_bib0250","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2012.10.002","article-title":"Natural history of early, localized prostate cancer: a final report from three decades of follow-up","volume":"63","author":"Popiolek","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1667\/RR0527.1","article-title":"Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects","volume":"167","author":"Suit","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.canrad.2016.02.009_bib0260","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries","volume":"12","author":"Berrington de Gonzalez","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0265","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ijrobp.2003.12.003","article-title":"Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie\/Hospital Cochin (Paris) Group","volume":"59","author":"Chauveinc","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0360-3016(99)00559-3","article-title":"Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy","volume":"47","author":"Trotti","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0275","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.canrad.2016.02.009_bib0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(98)00006-6","article-title":"A dose-response study for I-125 prostate implants","volume":"41","author":"Stock","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0285","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brachy.2010.08.001","article-title":"Counterpoint: there is a dose-response relationship in the low-dose rate brachytherapy management of prostate cancer","volume":"9","author":"Stock","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2016.02.009_bib0290","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brachy.2013.11.009","article-title":"Does dose matter? Editorial comments to Morris et al. Whole prostate D90 and V100: a dose-response analysis of 2000 consecutive (125I) monotherapy cases","volume":"13","author":"Stone","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2016.02.009_bib0295","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2014.08.340","article-title":"A dose\u2013response analysis of biochemical control outcomes after (125I) monotherapy for patients with favorable-risk prostate cancer","volume":"90","author":"Shiraishi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.brachy.2010.08.002","article-title":"Point: the relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: is there an elephant in the room?","volume":"9","author":"Morris","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2016.02.009_bib0305","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brachy.2013.11.010","article-title":"Rebuttal to Drs Stone and Stock","volume":"13","author":"Spadinger","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2016.02.009_bib0310","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2012.06.014","article-title":"Prostate post-implant dosimetry: interobserver variability in seed localisation, contouring and fusion","volume":"104","author":"De Brabandere","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0315","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.urology.2009.04.060","article-title":"Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience","volume":"74","author":"Anderson","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.canrad.2016.02.009_bib0320","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0360-3016(02)04600-X","article-title":"Long-term urinary quality of life after permanent prostate brachytherapy","volume":"56","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0325","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ijrobp.2014.06.037","article-title":"Late urinary side effects 10 years after low-dose-rate prostate brachytherapy: population-based results from a multiphysician practice treating with a standardized protocol and uniform dosimetric goals","volume":"90","author":"Keyes","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0330","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.radonc.2014.12.001","article-title":"Severe rectal complications after prostate brachytherapy","volume":"114","author":"Wallner","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0335","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.PPO.0000260917.97290.70","article-title":"Long-term rectal function after permanent prostate brachytherapy","volume":"13","author":"Merrick","year":"2007","journal-title":"Cancer J"},{"key":"10.1016\/j.canrad.2016.02.009_bib0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brachy.2011.05.007","article-title":"Rectal toxicity and rectal dosimetry in low-dose-rate (125I) permanent prostate implants: a long-term study in 1006 patients","volume":"11","author":"Keyes","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2016.02.009_bib0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.brachy.2012.02.005","article-title":"Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer","volume":"11","author":"Orio","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2016.02.009_bib0350","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijrobp.2004.10.001","article-title":"Erectile function after prostate brachytherapy","volume":"62","author":"Merrick","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0355","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2008.11.058","article-title":"Erectile function durability following permanent prostate brachytherapy","volume":"75","author":"Taira","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.02.009_bib0360","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1464-410X.2011.10800.x","article-title":"Long-term potency preservation following brachytherapy for prostate cancer","volume":"110","author":"Snyder","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.canrad.2016.02.009_bib0365","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.radonc.2014.04.017","article-title":"Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer","volume":"112","author":"Ong","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.02.009_bib0370","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.brachy.2015.01.001","article-title":"Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy","volume":"14","author":"Keyes","year":"2015","journal-title":"Brachytherapy"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321816300476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321816300476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:24:37Z","timestamp":1761135877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321816300476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1278321816300476"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2016.02.009","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term results of permanent implant prostate cancer brachytherapy: A single-institution study of 675 patients treated between 1999 and 2003","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}